Journey Medical Corporation DERM Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.59M— | -$11.43M— | —— | —— | —— | ||
| $5.95M-1.0% | $6.29M+3.1% | $5.89M+12.2% | $5.68M+36.2% | $6.02M+78.7% | ||
| -$6.7M— | -$12.44M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $12.85M-33.2% | $16.23M-6.1% | $21.42M— | $14.38M— | $19.25M— | ||
| —— | —— | $2.49M— | -$3.62M— | -$2.99M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Journey Medical Corporation generate?
- Journey Medical Corporation (DERM) generated -$6.7M in operating cash flow over the trailing twelve months.
- Where does Journey Medical Corporation's cash flow data come from?
- Every line is extracted from Journey Medical Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
